News about Market

G Square Backs Serres in Majority Acquisition to Drive Global Growth

G Square, a European healthcare-focused private equity firm investing in high-growth mid-market companies, has signed an agreement to acquire a majority stake in Serres, a global leader in sustainable surgical fluid management solutions.

Market | 21/01/2026 | By Darshana |  243

Lupin Partners with Galenicum to Commercialise Injectable Semaglutide

Global pharmaceutical major Lupin Limited has entered into a licensing and supply agreement with Galenicum Health, S.L.U. through its subsidiary, Lupin Atlantis Holdings SA (LAHSA), for finished injectable formulations of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.

Market | 21/01/2026 | By Darshana |  291

Infinitopes Raises USD 35.1 Million to Advance Precision Cancer Vaccine into First-in-Human Trial

Infinitopes, a clinical-stage biotechnology company developing cancer vaccines, has completed the second close of its seed financing round, raising an additional USD 15.4 million and bringing total funds secured to USD 35.1 million.

Market | 21/01/2026 | By Darshana |  165

Bayer and VUMC Partner to Advance Cardiovascular and Kidney Therapies

The collaboration will focus initially on cardiovascular and kidney diseases, combining Bayer’s drug development expertise with Vanderbilt University Medical Center’s extensive data resources to generate data-driven insights and accelerate the discovery and development of new therapies addressing significant unmet medical needs.

Market | 21/01/2026 | By News Bureau |  156

Insilico Medicine, Hygtia Therapeutics Partner to Co-Develop AI-Designed NLRP3 Inhibitor for CNS Disorders

Insilico Medicine and Hygtia Therapeutics have entered a co-development deal for ISM8969, an AI-designed, brain-penetrant NLRP3 inhibitor, with milestone payments of up to USD 66 million.

Market | 21/01/2026 | By News Bureau |  223

Worldwide Clinical Trials to Acquire Catalyst Clinical Research

Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research, a move aimed at expanding its functional service provider capabilities, strengthening its global site network, boosting oncology expertise, and accelerating technology integration to enhance efficiency and transparency for customers.

Market | 21/01/2026 | By News Bureau |  287

JB Chemicals Delivers Strong Q3 FY26 Results with Double-Digit Growth

JB Chemicals and Pharmaceuticals Ltd (JB Pharma) reported a strong financial performance for the third quarter of FY26, with consolidated revenue rising to INR 1,065 crore, an increase of around 11 percent compared to the same quarter last year.

Market | 20/01/2026 | By Darshana |  216

Syngene Renews Long-Term Research Alliance with Bristol Myers Squibb Until 2035

Syngene International has extended its long-term research collaboration with Bristol Myers Squibb until 2035, expanding the partnership to cover integrated services across the drug development lifecycle, from discovery and translational sciences to manufacturing, clinical trials and commercialisation support.

Market | 20/01/2026 | By News Bureau |  100

Rakuten Medical and LOTTE Biologics Sign Manufacturing Deal for Global Oncology Programme

Rakuten Medical has entered into a manufacturing agreement with LOTTE Biologics under which LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates, supporting Rakuten Medical’s global clinical development programmes and future commercialisation in oncology.

Market | 19/01/2026 | By News Bureau |  181

Sun Pharma Launches UNLOXCYT for Advanced Cutaneous Squamous Cell Carcinoma

Sun Pharma has announced the US availability of UNLOXCYT for adults with metastatic or locally advanced cutaneous squamous cell carcinoma who are not eligible for curative surgery or radiation. The updated label includes long-term data supporting durable efficacy and a favourable tolerability profile.

Market | 16/01/2026 | By News Bureau |  119